Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2065-2075
Published online before print April 2, 2007, doi: 10.1161/CIRCULATIONAHA.107.688523
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/15/2065    most recent
CIRCULATIONAHA.107.688523v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitamoto, S.
Right arrow Articles by Shi, G.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitamoto, S.
Right arrow Articles by Shi, G.-P.
Related Collections
Right arrow Pathophysiology
Right arrow Genetically altered mice

(Circulation. 2007;115:2065-2075.)
© 2007 American Heart Association, Inc.


Vascular Medicine

Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Knockout Mice

Shiro Kitamoto, MD; Galina K. Sukhova, PhD; Jiusong Sun, PhD; Min Yang, MD, PhD; Peter Libby, MD; Victoria Love, PhD; Paurene Duramad, PhD; Chongxiu Sun, PhD; Yadong Zhang, PhD; Xiuwei Yang, PhD; Christoph Peters, PhD; Guo-Ping Shi, DSc

From the Departments of Medicine (S.K., G.K.S., J.S., M.Y., P.L., C.S., Y.Z., G.S.) and Pathology (V.L., P.D.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass; Department of Medicine, Dana Farber Cancer Institute and Harvard Medical School (X.Y.), Boston, Mass; and Institut für Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universität Freiburg (C.P.), Freiburg, Germany.

Correspondence to Guo-Ping Shi, DSc, Cardiovascular Medicine, NRB-7, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail gshi{at}rics.bwh.harvard.edu

Received August 1, 2006; accepted January 30, 2007.

Background— Remodeling of the arterial extracellular matrix participates importantly in atherogenesis and plaque complication. Increased expression of the elastinolytic and collagenolytic enzyme cathepsin L (Cat L) in human atherosclerotic lesions suggests its participation in these processes, a hypothesis tested here in mice.

Methods and Results— We generated Cat L and low-density lipoprotein receptor (LDLr) double-deficient (LDLr–/–Cat L–/–) mice by crossbreeding Cat L–null (Cat L–/–) and LDLr-deficient (LDLr–/–) mice. After 12 and 26 weeks of a Western diet, LDLr–/–Cat L–/– mice had significantly smaller atherosclerotic lesions and lipid cores compared with littermate control LDLr–/–Cat L+/– and LDLr–/–Cat L+/+ mice. In addition, lesions from the compound mutant mice showed significantly reduced levels of collagen, medial elastin degradation, CD4+ T cells, macrophages, and smooth muscle cells. Mechanistic studies showed that Cat L contributes to the degradation of extracellular matrix elastin and collagen by aortic smooth muscle cells. Smooth muscle cells from LDLr–/–Cat L–/– mice or those treated with a Cat L–selective inhibitor demonstrated significantly less degradation of elastin and collagen and delayed transmigration through elastin in vitro. Cat L deficiency also significantly impaired monocyte and T-lymphocyte transmigration through a collagen matrix in vitro, suggesting that blood-borne leukocyte penetration through the arterial basement membrane requires Cat L. Cysteine protease active site labeling demonstrated that Cat L deficiency did not affect the activity of other atherosclerosis-associated cathepsins in aortic smooth muscle cells and monocytes.

Conclusions— Cat L directly participates in atherosclerosis by degrading elastin and collagen and regulates blood-borne leukocyte transmigration and lesion progression.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. K. Swirski, R. Weissleder, and M. J. Pittet
Heterogeneous In Vivo Behavior of Monocyte Subsets in Atherosclerosis
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1424 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert
Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis
J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan
Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]